Expediting Drug Development: FDA’s New Regenerative Medicine Advanced Therapy Designation
Crossref DOI link: https://doi.org/10.1177/2168479018779373
Published Online: 2019-12-23
Published Print: 2019-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vaggelas, Annegret https://orcid.org/0000-0003-3578-0054
Seimetz, Diane
Text and Data Mining valid from 2019-05-01
Article History
Received: 27 November 2017
Accepted: 4 May 2018
First Online: 23 December 2019